ABUS vs MSFT: Which Stock is Better?
Side-by-side comparison of Arbutus Biopharma Corp and Microsoft Corporation in 2026
ABUS
Arbutus Biopharma Corp
—
MSFT
Microsoft Corporation
$385.10
Key Metrics Comparison
| Metric | ABUS | MSFT | Winner |
|---|---|---|---|
| Market Cap | $882.99M | $3.71T | MSFT |
| P/E Ratio | 5.39 | 38.61 | ABUS |
| EPS (TTM) | $N/A | $N/A | Tie |
| Revenue Growth | 0.0% | 0.0% | Tie |
| Gross Margin | 0.0% | 0.0% | Tie |
Analyze ABUS
Full quant analysis
Analyze MSFT
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is ABUS or MSFT a better investment?
Comparing ABUS and MSFT: Arbutus Biopharma Corp has a market cap of $882.99M while Microsoft Corporation has $3.71T. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between ABUS and MSFT?
ABUS (Arbutus Biopharma Corp) and MSFT (Microsoft Corporation) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: ABUS or MSFT?
Based on P/E ratios, ABUS trades at a lower multiple (5.4x vs 38.6x).
Which is growing faster: ABUS or MSFT?
Both ABUS and MSFT show similar growth rates. Check our detailed analysis for quarterly trends.
Which company is more profitable: ABUS or MSFT?
Both companies show comparable profitability metrics. View the full comparison above for detailed analysis.
Which is the larger company: ABUS or MSFT?
Microsoft Corporation (MSFT) is larger with a market cap of $3.71T compared to $882.99M for ABUS.
Should I buy ABUS or MSFT in 2026?
Both ABUS and MSFT have investment merit. ABUS trades at $N/A while MSFT trades at $385.10. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between ABUS and MSFT stock?
Key differences: Market Cap ($882.99M vs $3.71T), P/E Ratio (5.4x vs 38.6x), Revenue Growth (0.0% vs 0.0%), Gross Margin (0.0% vs 0.0%).
Should I buy ABUS or MSFT in 2026?
The choice between ABUS and MSFT depends on your investment goals. MSFT shows higher revenue growth (0.0%). MSFT has better margins (0.0%). Consider your risk tolerance and time horizon.
What is the market cap comparison between ABUS and MSFT?
ABUS (Arbutus Biopharma Corp) has a market cap of $882.99M, while MSFT (Microsoft Corporation) has a market cap of $3.71T. MSFT is the larger company by market value.